Mr. Robert J. Flanagan, CPA, is an Independent Director at W.P. Carey, Inc., a Chief Executive Officer at Clark Enterprises, Inc., an Independent Director at W.P. Carey, Inc. (Real Estate), an Investment Partner at Alfred Street Partners LLC and a President at Clark Enterprises, Inc.

He is on the Board of Directors at W.P. Carey, Inc., Brown Advisory, Inc., Hamilton Pharmaceuticals, Inc., OfficeArrow LLC, SnagFilms, Inc., Svelte Medical Systems, Inc., Vascular Therapies, Inc., Verax Biomedical, Inc., W.P. Carey, Inc. (Real Estate) and The Clark Foundation.

Mr. Flanagan was previously employed as a Chairman by The Federal City Council, a Chairman by Sagent Pharmaceuticals, Inc., a Chairman by Martek Biosciences Corp., a Managing Director by CNF Investments LLC, a Secretary, Treasurer & Director by Baltimore Orioles LP, a Member-Audit Division by Arthur Andersen LLP, and a Member by The Economic Club of Washington.

He also served on the board at Sagent Holdings Co., Aquestive Therapeutics, Inc., Castle Brands, Inc., Angel Medical Systems, Inc., Brown Advisory Group Holdings LLC and ILD Corp.

Mr. Flanagan received a BS in Business Administration from Georgetown University, an MST from the American University School of Business and is a Certified Public Accountant licensed in Washington, DC.